News Archives - Page 384 of 612

MondaySep 21, 2020 3:08 pm

Trxade Group, Inc. (NASDAQ: MEDS) Showcases Prescription Affordability Efforts During Virtual Investor Summit

Pharmaceutical industry services provider Trxade Group Inc. presented an overview of the company’s structure and strategy at this month’s LD 500 invitational microcap investor summit The investor summit was a virtual gathering place during the ongoing pandemic, providing brand and industry information through webcasts to more than 20,000 attendees representing hundreds of companies Trxade Group is dedicated to helping its growing network of independent pharmacies compete with big box chains through a supply chain trading platform that delivers transparent product pricing and availability information Trxade Group is also developing its nascent B2C operations with Telehealth services that link home-bound or…

MondaySep 21, 2020 1:49 pm

KBL Merger Corp. IV (NASDAQ: KBLM) (NASDAQ: KBLMR) (NASDAQ: KBLMW) Fulfilling IPO Goal Through Merger With 180 Life Sciences Corp.

KBL Merger Corp. IV is set to finalize the acquisition of 180 Life Sciences Corp. during Q4 2020 180 Life Sciences Corp. has several ongoing programs at different stages of development, with the leading candidate in Phase 2b/3, helping mitigate the risks involved with its drug development The merger with 180 Life Sciences will enable KBL Merger Corp. IV to enter a market expected to double in size by 2027 180 Life Sciences is growing its patent portfolio through several preclinical studies beginning in two additional areas of inflammatory novel drug studies KBL Merger Corp. (NASDAQ: KBLM) (KBL Merger Corp.…

MondaySep 21, 2020 1:08 pm

Pure Extract Technologies Inc. Sets Sights on Functional Mushroom Industry

Pure Extract Technologies focuses on extraction of volatile plant molecules Company has recently announced entry into functional mushroom market, providing extraction services Pure Extract applying for Natural Health Products site license with Health Canada, which will help ensure that high quality standards will be upheld while also lending Company sales entry into foreign markets Company is set to focus on development of tinctures, soft-gel products, followed by move into creating beverage formulations as well as oral and nasal sprays Pure Extract Technologies, (“Pure Extracts”) a Pemberton, British Columbia-domiciled private plant extraction company, has a successful history as the supplier of…

MondaySep 21, 2020 11:14 am

Predictive Oncology Inc. (NASDAQ: POAI) Subsidiary’s CIO Discusses Curing Cancer with AI on DojoLIVE! Interview

POAI subsidiary Helomics exec discusses the company’s quest to fight cancer Helomics tapping into the fast growing, billion-dollar AI in drug discovery market Pittsburgh-based company has been building foundational groundwork in cancer drug response profiling for two decades Helomics harnesses rich historic tumor data with the power of AI to test living tumor tissues Predictive Oncology (NASDAQ: POAI), a knowledge-driven company focused on applying artificial intelligence (“AI”) to personalized medicine and drug discovery, announced that one of its executives, Helomics CIO Mark Collins, PhD, recently appeared on DojoLIVE! (https://ibn.fm/hSAn4). Helomics, a POAI subsidiary, applies artificial intelligence to its rich data gathered…

FridaySep 18, 2020 12:52 pm

Cybin Corp. New CEO Set to Pave Path to Profitability, Grow IP Portfolio Organically

Cybin announces appointment of established pharma industry figure as new CEO Drysdale leverages 30 years of leadership, entrepreneurial experience in life-science space Announcement comes as Cybin sets out on path to profitability Cybin Corp., an innovative life science company developing mushroom-derived psychedelic pharmaceuticals and nonpsychedelic nutraceutical products, has announced the appointment of Mr. Doug Drysdale as the company’s Chief Executive Officer. With more than three decades of experience, the new leader recognizes psychedelics as a major breakthrough in treating mental health conditions. Drysdale joins Cybin to pave the road for the company’s rapid growth, underpinned by the recent strong push…

FridaySep 18, 2020 11:54 am

Zacks Initiates Research on Net Element (NETE); Predicts $30 Per Share Target Price

Net Element’s reverse merger with EV manufacturer Mullen Technologies expected to close by 4Q2020 NETE expects to begin marketing Dragonfly K50, sold in conjunction with JV partner Qiantu Motors from 2Q2021 Company will also break ground in early 2021 on 1.5 million square foot facility to manufacture, assemble its own vehicles Zacks forecasts that NETE could snag $30/share valuation by merger’s close Net Element Inc. (NASDAQ: NETE), a financial technology company which has recently transformed its business model to become a pure-play electric vehicle (“EV”) manufacturer, was recently the subject of a company initiation report published by Zacks Small-Cap Research (https://ibn.fm/XGMRy).…

ThursdaySep 17, 2020 12:30 pm

The Alkaline Water Company Inc. (CSE: WTER) (NASDAQ: WTER) Reports Record Numbers, Ranks in Top-10 Nielsen Report

In its most recent SEC filings, WTER announced record first-quarter revenue of $14.2 million Alkaline88 ranked as 10th best-selling value-added water and third fastest-growing value-added water in Nielsen report WTER marks milestone by adding the largest food-service redistributor to its growing list of channel partners The Alkaline Water Company (CSE: WTER) (NASDAQ: WTER) continues its impressive upward trajectory, releasing record numbers in its latest financial report and ranking in a top-10 category in a recent Nielson report. In addition, with the announcement of its recent distribution agreement with DOT Foods, the company is aggressively expanding into the hospitality channel. In…

ThursdaySep 17, 2020 11:28 am

CNS Pharmaceuticals, Inc. (NASDAQ: CNSP) Sub-Licensee Partner Announces CRO for Phase 1 and Phase 2 Berubicin Trials in Poland

Poland trials will include the first ever Phase 1 trial for pediatric patients suffering from glioblastoma multiforme CNS Pharmaceuticals has made significant strides in its Berubicin manufacturing process due to its dual-track approach and expects to begin production of its drug candidate at Pharmaceuticals International during the third quarter of 2020 The Company’s CFO recently acquired 142,000 shares of common stock in the open market, a move indicative of his confidence in the success of Berubicin clinical trials and its positive impact on the global brain tumor therapeutics market CNS Pharmaceuticals (NASDAQ: CNSP) is moving forward with clinical trials of…

ThursdaySep 17, 2020 10:53 am

Mobius Interactive Ltd. CEO Talks Rise of eSports, Record Number of Players in Magazine Feature Article

Worldwide number of esports gamers predicted to reach 2.7 billion this year Pandemic forced closure of traditional sports, leaving sports bettors with few options Mobius CEO Lynn Pearce notes it is “remarkably interesting to see how much money is being raised for those participating in the esports arena” In the wake of COVID-19, eSports is gaining exposure and popularity with a predicted 2.7 billion gamers playing worldwide by the end of this year, says Mobius Interactive CEO Lynn Pearce in the most recent issue of “Infinity Gaming” (http://ibn.fm/Rpsux). Pearce, an experienced, data-driven, commercially focused, strategic brand marketer with more than 15…

Site Search

Company Search

Category: News